Two Stocks Under $30 Draw Investor Attention as Samsara and Evolv Technologies Show Strong Growth Potential
Two Stocks Under $30 Draw Investor Attention as Samsara and Evolv Technologies Show Strong Growth Potential
Two stocks under $30, Samsara and Evolv Technologies, are gaining attention after recent market analysis highlighted strong revenue growth, improving profitability, and notable analyst optimism. The original report from 24/7 Wall St. focused on Samsaraâs recurring revenue strength and Evolv Technologiesâ growth in AI-powered security screening.
Market Focus Shifts Toward Affordable Growth Stocks
Investors are once again looking closely at lower-priced growth stocks, especially companies tied to automation, artificial intelligence, connected operations, and subscription-based software. While a stock price under $30 does not automatically make a company cheap, it can make the shares more accessible to retail investors who want exposure to fast-growing technology themes.
Two names now standing out are Samsara Inc. (NYSE: IOT) and Evolv Technologies Holdings Inc. (NASDAQ: EVLV). Both companies operate in markets connected to automation and AI, but they serve different industries. Samsara focuses on connected operations for fleets, equipment, and physical assets. Evolv Technologies develops AI-based security screening systems used in locations such as schools, hospitals, workplaces, and large venues.
Samsara Shows Strong Recurring Revenue Momentum
Samsara has become one of the more closely watched names in connected operations software. Its platform helps companies track fleets, monitor equipment, improve driver safety, and use real-time data to manage physical operations more efficiently.
According to the report, Samsara shares recently traded around $29.07, keeping the stock below the $30 level. Even though the share price has pulled back over the past year, the companyâs business performance has remained strong.
Samsara reported quarterly revenue of $415.98 million, representing 29.2% year-over-year growth. The company also posted non-GAAP earnings per share of $0.15, beating analyst expectations cited in the report. Most importantly, Samsara achieved its first quarter of GAAP profitability, a key milestone for a fast-growing software company.
Why Analysts Remain Positive on Samsara
Wall Street analysts appear optimistic about Samsaraâs future. The report noted that the company had 18 positive ratings, including 15 Buy ratings and 3 Strong Buy ratings. The average analyst price target was listed at $44.17, implying roughly 51% upside from the recent share price.
One major reason for the optimism is Samsaraâs annual recurring revenue, or ARR. ARR reached $1.75 billion, up 29% year over year. Large customers are also becoming more important to the business, with customers generating more than $100,000 in ARR now representing over $1 billion of total ARR.
Samsaraâs Main Risk Is Valuation
Despite the strong growth, Samsara is not risk-free. The stock still trades at a premium valuation. The report noted that forward earnings and price-to-sales metrics remain high, meaning investors are already paying for strong future growth.
If enterprise spending slows, sales cycles lengthen, or industrial demand weakens, Samsaraâs share price could remain volatile. However, for investors who believe in long-term automation and connected operations, the recent pullback may make the stock worth watching.
Evolv Technologies Offers a Smaller, Higher-Risk AI Opportunity
Evolv Technologies is a very different type of investment. The company provides AI-powered screening systems designed to detect potential threats in public and private spaces. Its technology is used in high-traffic areas where fast and less disruptive screening is important.
The report said Evolv shares recently traded around $6.92, making the stock far cheaper on a per-share basis than Samsara. The stock was also up more than 55% over the past year, showing that investors have already begun to reward the companyâs growth story.
For fiscal 2025, Evolv generated revenue of $145.9 million, up 40.5%. The company also reported positive operating cash flow of $18.67 million, an encouraging sign for a smaller growth company.
Evolvâs Subscription Model Supports the Bull Case
A key part of Evolvâs investment story is recurring revenue. The companyâs ARR reached $120.5 million, up 21%. The report also noted that roughly half of 2026 deployments are expected to follow a pure-subscription model.
This matters because subscription revenue can make future sales more predictable. When customers pay through recurring contracts, companies often gain better revenue visibility and may improve margins over time.
Evolv Still Carries Clear Execution Risks
Even with strong revenue growth, Evolv has several risks investors should consider. The company missed fourth-quarter estimates, with revenue of $38.50 million compared with an expected $43.71 million. Gross margin also declined, falling from 57.5% to 48.4%.
The report also highlighted a material weakness in internal controls. That type of issue can concern investors because it may point to problems in financial reporting processes or corporate controls. While these issues do not automatically destroy the investment case, they do mean Evolv is likely better suited for risk-tolerant investors.
Comparing Samsara and Evolv Technologies
| Company | Ticker | Recent Price | Main Growth Driver | Key Risk |
|---|---|---|---|---|
| Samsara | IOT | About $29 | Connected operations and recurring software revenue | High valuation |
| Evolv Technologies | EVLV | About $7 | AI-powered security screening subscriptions | Execution and internal control concerns |
Bottom Line
Samsara and Evolv Technologies both offer exposure to powerful technology themes, including automation, AI, recurring revenue, and digital transformation. Samsara appears to be the stronger and more established business, supported by rapid ARR growth, improving profitability, and broad analyst confidence.
Evolv Technologies, meanwhile, offers a lower-priced and more speculative opportunity. Its growth rate is attractive, but investors must weigh that against missed estimates, margin pressure, and control-related concerns.
For investors, the main lesson is simple: a stock under $30 can be interesting, but price alone is not enough. Business quality, revenue growth, profitability, valuation, and risk all matter. Samsara may appeal to growth investors looking for a stronger operating profile, while Evolv may attract those willing to accept higher risk for potentially higher reward.
This article is for informational purposes only and is not financial advice. Investors should conduct their own research or speak with a qualified financial advisor before making investment decisions.
#SamsaraStock #EvolvTechnologies #GrowthStocks #AIInvesting #SlimScan #GrowthStocks #CANSLIM